CAMbrella

CAMbrella does not conduct its own research activities but will build up a network of different European research institutions in the field of complementary medicine and will foster international cooperation.

In different working groups, the scientists will work, amongst others,  on the following topics:

• Develop a consensus-based terminology widely accepted in Europe to describe CAM interventions
• Questions on methodology in scientific research on complementary medicine
• Review the current legal status and policies governing CAM provision in the EU and the relevance of CAM in the respective health care systems
• Explore the needs, believes and attitudes of the EU citizens to CAM and  create a knowledge base of patient demand for CAM and its prevalence

CAMbrella will draw a comprehensive picture of the current situation in CAM research in Europe, which will serve as a starting point for future research activities. Based on this information the CAMbrella consortium will create a roadmap that will enable a sustainable and prioritised EU research roadmap to CAM.

CAMbrella’s stakeholders are:

•  organisations and umbrella associations that represent patients and practitioners/clinicians
• practitioners and clinical providers
• manufacturers of pharmaceuticals in CAM
• political decision makers
• the interested public in Europe

Several large organisations and umbrella associations are already cooperating in close contact with CAMbrella via their membership  in the Advisory Board and will disseminate the results among their members.
Other channels for the dissemination of results are workshops, publications, participation on conferences and the website www.cambrella.eu.

BayFOR is involved in the Management and Dissemination of the project.

Our main tasks are the administrative and financial management of the project, organisational dissemination support and the maintenance of a web-based project platform.

CAMbrella was funded by the Seventh Framework Programme (FP7) of the European Commission (budget: 1.5 million euro).

Three-year project duration: 01 January 2010 - 31 December 2012

The CAMbrella consortium is coordinated by Dr. Wolfgang Weidenhammer (Klinikum Rechts der Isar, Technical University of Munich). It encompasses 16 highly respected scientific partners from 12 European countries and an advisory board which represents the relevant stakeholders (e.g. patients, manufacturers of herbal and homeopathic products, practitioners from different areas of therapies). The partners are located in Germany, Austria, Switzerland, Norway, Sweden, Denmark, France, Italy, Spain, England, Rumania and Hungary.

Zentrum für naturheilkundliche Forschung, Klinikum Rechts der Isar, Technische Universität München, Germany
Wiener Internationale Akademie für Ganzheitsmedizin, Austria
Universitetet i Tromsø, Norway
Universität Bern, Switzerlandeiz
Charité – Universitätsmedizin Berlin, Germany
Universitätsspital Zürich, Switzerland
Comitato Permanente di Consenso e Coordinamento per le Medicine Non-Convenzionali in Italia, Italy
Karolinska Institutet, Sweden
Université de Paris 13, France
Servicio Andaluz de Salud, Spain
Agenzia sanitaria e sociale regionale – Regione Emilia-Romagna, Italy
Pési Tudományegyetem – University of Pecs, Hungary
Universitatea de Medicina si Farmacie Victor Babes Timisoara, Romania
Syddansk Universitet, Denmark
University of Southampton, UK
Bayerische Forschungsallianz GmbH, Germany

Further information on the CAMbrella project is available under: www.cambrella.eu.